Literature DB >> 27376496

Detailed Investigation of the Immunodominant Role of O-Antigen Stoichiometric O-Acetylation as Revealed by Chemical Synthesis, Immunochemistry, Solution Conformation and STD-NMR Spectroscopy for Shigella flexneri 3a.

Julien Boutet1,2,3,4, Pilar Blasco5,4, Catherine Guerreiro1,2, Françoise Thouron6,7, Sylvie Dartevelle8,9, Farida Nato8,9, F Javier Cañada5, Ana Ardá5,10, Armelle Phalipon6,7, Jesús Jiménez-Barbero11,12,13, Laurence A Mulard14,15.   

Abstract

Shigella flexneri 3a causes bacillary dysentery. Its O-antigen has the {2)-[α-d-Glcp-(1→3)]-α-l-Rhap-(1→2)-α-l-Rhap-(1→3)-[Ac→2]-α-l-Rhap-(1→3)-[Ac→6]≈40 % -β-d-GlcpNAc-(1→} ([(E)ABAc CAc D]) repeating unit, and the non-O-acetylated equivalent defines S. flexneri X. Propyl hepta-, octa-, and decasaccharides sharing the (E')A'BAc CD(E)A sequence, and their non-O-acetylated analogues were synthesized from a fully protected BAc CD(E)A allyl glycoside. The stepwise introduction of orthogonally protected mono- and disaccharide imidate donors was followed by a two-step deprotection process. Monoclonal antibody binding to twenty-six S. flexneri types 3a and X di- to decasaccharides was studied by an inhibition enzyme-linked immunosorbent assay (ELISA) and STD-NMR spectroscopy. Epitope mapping revealed that the 2C -acetate dominated the recognition by monoclonal IgG and IgM antibodies and that the BAc CD segment was essential for binding. The glucosyl side chain contributed to a lesser extent, albeit increasingly with the chain length. Moreover, tr-NOESY analysis also showed interaction but did not reveal any meaningful conformational change upon antibody binding.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  NMR spectroscopy; antibodies; carbohydrates; epitope specificity; glycosylation

Mesh:

Substances:

Year:  2016        PMID: 27376496     DOI: 10.1002/chem.201600567

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  7 in total

1.  Exploratory N-Protecting Group Manipulation for the Total Synthesis of Zwitterionic Shigella sonnei Oligosaccharides.

Authors:  Debashis Dhara; Laurence A Mulard
Journal:  Chemistry       Date:  2021-03-01       Impact factor: 5.236

2.  The First-in-Human Synthetic Glycan-Based Conjugate Vaccine Candidate against Shigella.

Authors:  Robert M F van der Put; Carolien Smitsman; Alex de Haan; Martin Hamzink; Hans Timmermans; Joost Uittenbogaard; Janny Westdijk; Michiel Stork; Olga Ophorst; Françoise Thouron; Catherine Guerreiro; Philippe J Sansonetti; Armelle Phalipon; Laurence A Mulard
Journal:  ACS Cent Sci       Date:  2022-03-17       Impact factor: 18.728

3.  Structural characterisation of the capsular polysaccharide expressed by Burkholderia thailandensis strain E555:: wbiI (pKnock-KmR) and assessment of the significance of the 2-O-acetyl group in immune protection.

Authors:  Marc Bayliss; Matthew I Donaldson; Sergey A Nepogodiev; Giulia Pergolizzi; Andrew E Scott; Nicholas J Harmer; Robert A Field; Joann L Prior
Journal:  Carbohydr Res       Date:  2017-09-21       Impact factor: 2.975

4.  Increasing the Affinity of an O-Antigen Polysaccharide Binding Site in Shigella flexneri Bacteriophage Sf6 Tailspike Protein.

Authors:  Sonja Kunstmann; Olof Engström; Marko Wehle; Göran Widmalm; Mark Santer; Stefanie Barbirz
Journal:  Chemistry       Date:  2020-05-19       Impact factor: 5.236

5.  Structure of a protective epitope reveals the importance of acetylation of Neisseria meningitidis serogroup A capsular polysaccharide.

Authors:  Pedro Henriques; Lucia Dello Iacono; Ana Gimeno; Alessia Biolchi; Maria Rosaria Romano; Ana Arda; Gonҫalo J L Bernardes; Jesus Jimenez-Barbero; Francesco Berti; Rino Rappuoli; Roberto Adamo
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-06       Impact factor: 11.205

6.  Molecular Modeling of the Shigella flexneri Serogroup 3 and 5 O-Antigens and Conformational Relationships for a Vaccine Containing Serotypes 2a and 3a.

Authors:  Jason Hlozek; Sara Owen; Neil Ravenscroft; Michelle M Kuttel
Journal:  Vaccines (Basel)       Date:  2020-11-02

Review 7.  Toward a Multivalent Synthetic Oligosaccharide-Based Conjugate Vaccine against Shigella: State-of-the-Art for a Monovalent Prototype and Challenges.

Authors:  Armelle Phalipon; Laurence A Mulard
Journal:  Vaccines (Basel)       Date:  2022-03-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.